Company Filing History:
Years Active: 2013
Title: Brendan Canning: Innovator in Antitussive Compositions
Introduction
Brendan Canning is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of antitussive formulations. His innovative work has led to the creation of a patent that addresses important medical needs.
Latest Patents
Brendan Canning holds a patent for "Antitussive compositions comprising memantine." This patent describes compositions that include memantine along with various enhancers to improve absorption and elimination. The innovative approach taken in this patent aims to provide effective solutions for cough treatment.
Career Highlights
Canning is associated with Cerecor, Inc., a company focused on developing innovative therapies for central nervous system disorders. His work at Cerecor has allowed him to explore and implement his ideas in a collaborative environment, contributing to the advancement of medical treatments.
Collaborations
Brendan has worked alongside talented colleagues such as Blake Paterson and Mark Ginski. Their combined expertise fosters a creative atmosphere that enhances the development of new therapeutic solutions.
Conclusion
Brendan Canning's contributions to the field of antitussive compositions highlight his innovative spirit and dedication to improving healthcare. His patent and work at Cerecor, Inc. reflect his commitment to advancing medical science.